In this guide
What is Green Tea Extract?
Green tea extract concentrates catechins, especially EGCG, and may also contain caffeine. Weight effects are modest, while high-dose bolus extracts have produced liver-enzyme elevations and rare liver injury. No RDA, AI, UL or established weight-loss dose exists for green tea extract or EGCG. EFSA found that supplement intakes at or above 800 mg EGCG/day increased serum transaminases in trials; that is a hazard signal, not a safe-limit line. [1]
Typical Green Tea Extract Protocols
| Source and population | Form and amount each time | Frequency | Total exposure | Duration or boundary |
|---|---|---|---|---|
| Chen 2016 · 102 women with central obesity | Green tea extract providing 856.8 mg EGCG/day | Daily total; per-administration amount not reported in the abstract | 856.8 mg EGCG/day | 12 weeks; about 1.1 kg within-group loss |
| Dostal 2015/2017 · 1,075 postmenopausal women | Decaffeinated extract: 1,315 mg catechins, including 843 mg EGCG/day | Daily total; administration split not established here | 843 mg EGCG/day | 12 months; liver enzymes monitored |
| Lin 2020 · 25 randomized trials | Green-tea products and catechin doses varied | Study-specific | No universal regimen | Mean weight difference −1.78 kg; high heterogeneity |
These rows reproduce sources. Do not average them into one universal regimen.
From source to outcome
Not just extract milligrams.
Products and trials differ.
Enzyme elevations in trials.
Which forms and label details matter?
Record extract milligrams, total catechins, EGCG and caffeine separately, plus decaffeination claim and whether it is swallowed with food. Brewed tea and a concentrated capsule are not interchangeable.
How should it be stored?
Follow the label, close the container and protect it from heat, light and moisture.
Read the label before the claim
Extract mass is not active-compound mass.
Keep amount, frequency and duration together.
Weight, alertness and safety are separate outcomes.
What is it commonly used for?
It is used for weight management, metabolic biomarkers and antioxidant claims. Meta-analysis suggests a small average weight change, but formulations and results vary and the change is not a treatment-sized effect. [5]
What does human research show?
Chen randomized 102 women with central obesity to 856.8 mg EGCG/day or placebo for 12 weeks. Weight fell about 1.1 kg within the extract arm, a modest change, and the abstract reported no adverse events. [2] Lin pooled 25 randomized trials and estimated a −1.78 kg mean weight difference, with dose, product and duration explaining heterogeneity. [3] A large year-long trial enrolled 1,075 postmenopausal women and analyzed liver outcomes in 1,021 with normal baseline enzymes. The decaffeinated extract supplied about 1,315 mg catechins including 843 mg EGCG/day; 5.1% developed moderate or worse abnormalities in any liver-function measure, with an odds ratio of 7.0 versus placebo, and ALT normalized after dechallenge. [4] EFSA therefore identified 800 mg/day and above as a trial-based liver-enzyme hazard zone, while finding insufficient data to identify a safe dose below it. [1]

How might it act?
Catechins can influence fat oxidation and cell signalling, while caffeine blocks adenosine receptors and raises alertness. These mechanisms do not establish durable weight loss and do not neutralize liver risk.
How does it compare with related products?
| Ingredient | Label identity | Main evidence boundary |
|---|---|---|
| Green tea extract | EGCG, total catechins and caffeine | Small weight signals; concentrated extract can injure the liver |
| Caffeine | Milligrams from every source | Alertness and exercise effects trade off against sleep and withdrawal |
| Garcinia cambogia | Extract mass and hydroxycitric acid | Weight effect is absent or small; liver and psychiatric reports matter |
| Forskolin | Extract mass and standardized forskolin | Two small sex-specific trials do not establish weight loss |
What are the risks and interactions?
Concentrated extract can cause nausea, abdominal symptoms, higher blood pressure and liver injury. Avoid taking it fasting, do not combine multiple EGCG products, and count caffeine from all sources. Stop and seek prompt assessment for dark urine, jaundice, severe fatigue, persistent upper-right abdominal pain or vomiting.
Which medicines require review?
Review liver disease, hepatotoxic medicines, warfarin, stimulant use and iron deficiency. Tea catechins can reduce non-heme iron absorption; product caffeine can compound stimulant effects.
Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [6], [7]
What should be monitored?
Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.
What happens when it is stopped?
No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.
Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.
What do public communities report?
Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.
Common questions about Green Tea Extract
Is green tea extract the same as drinking tea?
No. Extract can concentrate EGCG and caffeine into a bolus.
Does it cause meaningful weight loss?
Average changes are small and heterogeneous.
Is 800 mg EGCG a safe upper limit?
No. EFSA identified that amount as a level associated with enzyme elevations, not a safe limit.
Should it be taken fasting?
Fasting can increase catechin exposure and is a liver-safety concern.
Is decaffeinated extract risk-free?
No. Removing caffeine does not remove concentrated catechins or liver risk.
What should I track?
EGCG, catechins, caffeine, each administration, meals, symptoms and review date.
Glossary
Terms for reading the evidence.
- Active amount
- The amount of the named active compound, distinct from total extract mass.
- Daily total
- The sum across administrations, which does not reveal the amount each time.
- Randomized trial
- A study assigning an intervention and comparator by chance.
- Surrogate outcome
- A measure such as energy expenditure that is not weight loss itself.
- Withdrawal
- Symptoms after reducing or stopping repeated exposure.
- Hepatotoxicity
- Liver injury caused by a substance or product.
How this guide was researched
Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.
Explore the sources
Sources preserve form, amount, frequency, population, duration and outcome.
Showing 7 sources
- 01
Scientific Opinion on the safety of green tea catechins ↗
Official safety opinion
Current page or report reviewed; scope and limits retained.
Detail: At least 800 mg EGCG/day from supplements increased transaminases; no safe lower threshold established.
- 02
Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. ↗
Randomized trial
Current page or report reviewed; scope and limits retained.
Detail: 102 women; 856.8 mg EGCG/day for 12 weeks; modest weight change.
- 03
The effect of green tea supplementation on obesity: A systematic review and dose-response meta-analysis of randomized controlled trials. ↗
Systematic review and meta-analysis
Current page or report reviewed; scope and limits retained.
Detail: 25 trials; small pooled weight change with important heterogeneity.
- 04
Effect of Green Tea Supplements on Liver Enzyme Elevation: Results from a Randomized Intervention Study in the United States. ↗
Randomized safety trial
Current page or report reviewed; scope and limits retained.
Detail: 1,075 enrolled; 1,021 analyzed for liver outcomes; 843 mg EGCG/day; 5.1% developed moderate or worse liver-function abnormalities.
- 05
Dietary Supplements for Weight Loss ↗
Official evidence review
Current page or report reviewed; scope and limits retained.
Detail: Weight evidence and liver-safety context.
- 06
Questions and Answers on Dietary Supplements ↗
U.S. regulatory overview
Current page or report reviewed; scope and limits retained.
Detail: Supplements generally lack efficacy preapproval.
- 07
Product Licensing ↗
Canadian licensing overview
Current page or report reviewed; scope and limits retained.
Detail: Finished natural health products require licensing and authorized labels.
No matching sources
Try a different term or show the full list.